Neuropathy 'prevention' info
dianetavegia
Member Posts: 1,942 Member
Shands Teaching Hospital article
Glutathione: Glutathione is a small protein that is involved in detoxification; it binds to toxins in the body and transforms them into a form that can be excreted in urine or bile. Glutathione appears to significantly reduce numbness and tingling in the extremities, which is a common side effect of the chemotherapy drug Eloxatin.
In a clinical trial that involved 52 patients with advanced colorectal cancer undergoing Eloxatin chemotherapy, half were treated with glutathione and the other half received a placebo (inactive substitute). After eight courses of chemotherapy, only 43% of patients treated with glutathione experienced peripheral neuropathy, compared to 79% of patients who received placebo. Severe numbness and tingling did not occur in any patients treated with GSH, but occurred in 26% of patients who received placebo. Glutathione did not alter the effectiveness of chemotherapy, as anticancer responses, progression-free survival, and overall survival at nearly one year were the same between the two groups of patients
Glutathione: Glutathione is a small protein that is involved in detoxification; it binds to toxins in the body and transforms them into a form that can be excreted in urine or bile. Glutathione appears to significantly reduce numbness and tingling in the extremities, which is a common side effect of the chemotherapy drug Eloxatin.
In a clinical trial that involved 52 patients with advanced colorectal cancer undergoing Eloxatin chemotherapy, half were treated with glutathione and the other half received a placebo (inactive substitute). After eight courses of chemotherapy, only 43% of patients treated with glutathione experienced peripheral neuropathy, compared to 79% of patients who received placebo. Severe numbness and tingling did not occur in any patients treated with GSH, but occurred in 26% of patients who received placebo. Glutathione did not alter the effectiveness of chemotherapy, as anticancer responses, progression-free survival, and overall survival at nearly one year were the same between the two groups of patients
0
Comments
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 396 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 537 Sarcoma
- 730 Skin Cancer
- 652 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards